The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Robert F. Kelley sits on this spectrum.
This scientist: 154 publications — 29th percentile
29% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 1,028 publications or more.
The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Robert F. Kelley sits on this spectrum.
This scientist: 59 D-Index — 38th percentile
38% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 167 D-Index or more.
Robert F. Kelley is affiliated with Genentech in the United States, where their research spans several key areas within biochemistry, genetics, molecular biology, and medicine. Their work focuses particularly on monoclonal and polyclonal antibodies, protein purification and stability, and the study of viral infectious diseases and gene expression in insects. Additional research interests include retinal diseases and treatments, transgenic plants, and diabetes and associated disorders.
The scientist has contributed to the following research topics:
Frequent publication venues for their work include:
Their recent papers highlight several aspects of biochemical and pharmaceutical research:
Robert F. Kelley has collaborated frequently with several coauthors, indicating consistent partnerships within their research network. Notable frequent collaborators include:
The subfields of study related to Robert F. Kelley's work cover various specialized areas such as molecular biology, radiology, nuclear medicine and imaging, ophthalmology, biotechnology, and immunology. These subfields reflect a multidisciplinary approach that integrates molecular techniques with clinical applications and imaging modalities.
Overall, Robert F. Kelley's scholarly contributions are situated at the interface of molecular biology and medicine, with a focus on therapeutic proteins and antibody research, emphasizing biochemical stability, pharmacokinetics, and bioactivity assessments within pharmaceutical sciences.
Sarah G. Hymowitz;Ellen H. Filvaroff;JianPing Yin;James Lee
Kim Newton;Marissa L. Matsumoto;Ingrid E. Wertz;Donald S. Kirkpatrick
Carter P;Kelley Rf;Rodrigues Ml;Snedecor B
S.G. Hymowitz;H.W. Christinger;G. Fuh;M.H. Ultsch
Marissa L. Matsumoto;Katherine E. Wickliffe;Ken C. Dong;Christine Yu
Robert F. Kelley;Klara Totpal;Stephanie H. Lindstrom;Mary Mathieu
Narendra B. Bam;Jeffrey L. Cleland;Janet Yang;Mark C. Manning
S.G. Hymowitz;M.P. O'Connell;M.H. Ultsch;A. Hurst
Teemu T. Junttila;Kathryn Parsons;Christine Olsson;Yanmei Lu
Lisa J. Garrard;Maria Yang;Mark P. O'Connell;Robert F. Kelley
Isidro Hötzel;Frank-Peter Theil;Lisa J. Bernstein;Saileta Prabhu
Sarah G. Hymowitz;Darshana R. Patel;Heidi J.A. Wallweber;Steven Runyon
Vikas K. Sharma;Thomas W. Patapoff;Bruce Kabakoff;Satyan Pai
Robert F. Kelley;Mark P. O'Connell
Mark Ultsch;Jack Bevers;Gerald Nakamura;Richard Vandlen
Muller Ya;Ultsch Mh;Kelley Rf;de Vos Am
Teemu T. Junttila;Ji Li;Jennifer A. Johnston;Maria L. Hristopoulos
Robert F. Kelley;Frederic M. Richards
Frederic A. Fellouse;Pierre A. Barthelemy;Robert F. Kelley;Sachdev S. Sidhu
Lilian Phu;Anita Izrael-Tomasevic;Marissa L. Matsumoto;Daisy J. Bustos
If you think any of the details on this page are incorrect, let us know.
University of Western Australia
University of Stuttgart
Chinese Academy of Sciences
Uppsala University
Weizenbaum-Institut
Ironwood Pharmaceuticals (United States)
National Institutes of Health
Pennsylvania State University
Texas A&M University
Chapman University
University Health Network
Roma Tre University
University of Melbourne
Université Libre de Bruxelles
University of Milan
Universität Hamburg
